Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 101 to 150 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
51\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj310o13.4 (novel protein similar to predicted c. elegans and c. intestinalis proteins) (fragment). [source:sptrembl;acc:q9nug5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7563.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8732.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15458\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 4 (neurod4). [source:swissprot;acc:q9hd90]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
779.167\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1390.33\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.78438\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
52\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromodomain helicase dna binding protein 5. [source:refseq;acc:nm\_015557]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like isoform b. [source:refseq;acc:nm\_178326]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
13195.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11486.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14883\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
53\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bcl2-related ovarian killer. [source:refseq;acc:nm\_032515]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4955.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5659.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14207\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin-dependent kinase 2-associated protein 1 (cdk2-associated protein 1) (putative oral cancer suppressor) (deleted in oral cancer- 1) (doc-1). [source:swissprot;acc:o14519]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
779.167\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1390.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.78438\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
54\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
deltex 2. [source:refseq;acc:nm\_020892]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1618.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2651.88\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.63814\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
septin-like protein kiaa0202 (fragment). [source:swissprot;acc:q92599]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13203.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
15033.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13859\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
55\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
deltex homolog 1; hdx-1. [source:refseq;acc:nm\_004416]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1629.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2662.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.63399\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
septin 10 isoform 1. [source:refseq;acc:nm\_144710]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
13081.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14872.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13694\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
56\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c4 (hox-3e) (cp19). [source:swissprot;acc:p09017]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13635\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
t-lak cell-originated protein kinase; spermatogenesis-related protein kinase; pdz-binding kinase; pbk; mapkk-like protein kinase; serine/threonine protein kinase. [source:refseq;acc:nm\_018492]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1631.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2664.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.63302\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
57\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-b4 (hox-2f) (hox-2.6). [source:swissprot;acc:p17483]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13635\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
kh domain containing, rna binding, signal transduction associated 3; sam68-like phosphotyrosine protein, t-star. [source:refseq;acc:nm\_006558]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1631.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2664.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.63302\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
58\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c5 (hox-3d) (cp11). [source:swissprot;acc:q00444]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13635\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
kh domain containing, rna binding, signal transduction associated 1; gap-associated tyrosine phosphoprotein p62 (sam68). [source:refseq;acc:nm\_006559]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1631.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2664.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.63302\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
59\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c6 (hox-3c) (hho.c8) (cp25). [source:swissprot;acc:p09630]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13635\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
kh domain-containing, rna-binding, signal transduction-associated protein 2; sam68-like mammalian protein 1. [source:refseq;acc:nm\_152688]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
1631.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2664.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.63302\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
60\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1,4-alpha-glucan branching enzyme (ec 2.4.1.18) (glycogen branching enzyme) (brancher enzyme). [source:swissprot;acc:q04446]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4489.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2765.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.6231\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-d4 (hox-4b) (hox-5.1) (hho.c13). [source:swissprot;acc:p09016]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13635\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
61\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen phosphorylase, brain form (ec 2.4.1.1). [source:swissprot;acc:p11216]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4489.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2765.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.6231\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-b5 (hox-2a) (hho.c10) (hu-1). [source:swissprot;acc:p09067]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13635\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
62\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen phosphorylase, liver form (ec 2.4.1.1). [source:swissprot;acc:p06737]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4489.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2765.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.6231\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-a5 (hox-1c). [source:swissprot;acc:p20719]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.13635\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
63\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-a4 (hox-1d) (hox-1.4). [source:swissprot;acc:q00056]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin xv (unconventional myosin-15). [source:swissprot;acc:q9ukn7]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4489.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
2765.82\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.6231\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
64\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen phosphorylase, muscle form (ec 2.4.1.1) (myophosphorylase). [source:swissprot;acc:p11217]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinal short-chain dehydrogenase/reductase 3. [source:refseq;acc:nm\_016246]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13635\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
65\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuralized-like. [source:refseq;acc:nm\_004210]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1657.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2690.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.6229\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
septin 6. [source:swissprot;acc:q14141]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13005.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
14773.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13593\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
66\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase subunit b17.2 (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b17.2) (ci-b17.2) (cib17.2) (13 kda differentiation-associated protein). [source:swissprot;acc:q9ui09]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1991.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
3221.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.61795\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
son protein (son3) (negative regulatory element-binding protein) (nre- binding protein) (dbp-5) (bax antagonist selected in saccharomyces 1) (bass1) (protein c21orf50). [source:swissprot;acc:p18583]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4900.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5555.81\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.13368\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
67\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 2 (arrestin, beta 2). [source:swissprot;acc:p32121]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hira-interacting protein 5 (cgi-33). [source:swissprot;acc:q9ums0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12176.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
13781.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1318\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
68\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 1 (arrestin, beta 1). [source:swissprot;acc:p49407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative glialblastoma cell differentiation-related; putative glialblastoma cell differentiation-related protein. [source:refseq;acc:nm\_016172]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
19498.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17265.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12932\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
69\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
amino acid transporter xat2; likely ortholog of mouse aspartate/glutamate transporter 1 (agt1). [source:refseq;acc:nm\_138817]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6991.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7848.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12253\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
spermatogenesis associated 6. [source:refseq;acc:nm\_019073]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
70\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
amp deaminase 2 (ec 3.5.4.6) (amp deaminase isoform l). [source:swissprot;acc:q01433]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
y+l amino acid transporter 1 (y(+)l-type amino acid transporter 1) (y+lat-1) (y+lat1) (monocyte amino acid permease 2) (mop-2). [source:swissprot;acc:q9um01]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6991.78\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7848.45\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.12253\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
71\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cystine/glutamate transporter (amino acid transport system xc-) (xct) (calcium channel blocker resistance protein ccbr1). [source:swissprot;acc:q9upy5]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, alpha isoform (pp2a, subunit b, b-alpha isoform) (pp2a, subunit b, b55-alpha isoform) (pp2a, subunit b, pr55-alpha isoform) (pp2a, subunit b, r2-alpha isoform). [source:swissprot;acc:q00007]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4556.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2945.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54716\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
72\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 7 (cationic amino acid transporter, y+ system), member 6. [source:refseq;acc:nm\_003983]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6991.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7848.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12253\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
uncharacterized hematopoietic stem/progenitor cells protein mds026. [source:sptrembl;acc:q9nz48]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4556.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2945.28\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54715\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
73\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 4b (eif-4b). [source:swissprot;acc:p23588]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6991.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7848.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12253\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, beta isoform (pp2a, subunit b, b-beta isoform) (pp2a, subunit b, b55- beta isoform) (pp2a, subunit b, pr55-beta isoform) (pp2a, subunit b, r2-beta isoform). [source:swissprot;acc:q00005]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4556.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2945.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54711\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
74\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
b(0,+)-type amino acid transporter 1 (b(0,+)at) (glycoprotein- associated amino acid transporter b0,+at1). [source:swissprot;acc:p82251]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6991.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7848.45\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.12253\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, gamma isoform (pp2a, subunit b, b-gamma isoform) (pp2a, subunit b, b55-gamma isoform) (pp2a, subunit b, pr55-gamma isoform) (pp2a, subunit b, r2-gamma isoform) (imypno1). [source:swissprot;acc:q9y2t4]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4556.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2945.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54694\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
75\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 18 kda subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-18 kda) (ci-18 kda) (complex i- aqdq) (ci-aqdq). [source:swissprot;acc:o43181]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1920.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2907.43\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.5137\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
septin 7 (cdc10 protein homolog). [source:swissprot;acc:q16181]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11616\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12942.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11418\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/